Cancer Research Cancer Epigenetics  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 28, 234-244, February 1, 1968]
© 1968 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gutmann, H. R.
Right arrow Articles by Foley, W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gutmann, H. R.
Right arrow Articles by Foley, W. A.

The Carcinogenicity of the o-Methoxy Derivatives of N-2-Fluorenylacetamide and of Related Compounds in the Rat1

H. R. Gutmann, S. B. Galitski and W. A. Foley

Laboratory for Cancer Research, Veterans Administration Hospital, and Department of Biochemistry, University of Minnesota, Minneapolis, Minnesota 55417

In order to test the idea that the lack of carcinogenicity of the o-amidofluorenols, N-(1-hydroxy-2-fluorenyl)acetamide and N-(3-hydroxy-2-fluorenyl)acetamide, is due to the hydrophilic phenolic hydroxyl group, the methylated derivatives, N-(1-methoxy-2-fluorenyl) acetamide and N-(3-methoxy-2-fluorenyl)acetamide as well as the hydrochlorides of 1-methoxy-2-fluorenamine and 3-methoxy-2-fluorenamine, were prepared, and their carcinogenicity was evaluated in the rat. N-(1-Methoxy-2-fluorenyl)acetamide and 1-methoxy-2-fluorenamine hydrochloride, when administered orally to male rats for 5 months, gave a tumor incidence of 27 and 50%, respectively. Approximately one-half of the lesions produced by either compound were adenocarcinomas of the small intestine. N-(3-Methoxy-2-fluorenyl)acetamide and 3-methoxy-2-fluorenamine hydrochloride were inactive. The low-to-moderate carcinogenicity of N-(1-methoxy-2-fluorenyl)acetamide and of 1-methoxy-2-fluorenamine hydrochloride contrasted sharply with the high carcinogenicity of the isomeric N-(7-methoxy-2-fluorenyl)acetamide and of N-2-fluorenyl acetamide, which were run for comparison under identical conditions. N-(7-Methoxy-2-fluorenyl) acetamide appeared to be specifically active toward the mammary gland.

The intracellular removal of the O-methyl group of N-(1-methoxy-2-fluorenyl)acetamide was demonstrated by means of N-(1-methoxy-2-fluorenyl)acetamide labeled with 14C in the methyl group. The formation of N-(1-hydroxy-2-fluorenyl)acetamide, indicated by the radioactive tracer experiments, was confirmed by the isolation of N-(1-hydroxy-2-fluorenyl)acetamide from the urine of rats dosed with N-(1-methoxy-2-fluorenyl)acetamide. The metabolic O-demethylation of N-(1-methoxy-2-fluorenyl)acetamide was compatible with the view that N-(1-hydroxy-2-fluorenyl)acetamide, when liberated in situ, may be weakly carcinogenic. However, the striking differences in the carcinogenicities, as well as in the sites of action of the o-methoxy compounds and of N-2-fluorenyl acetamide, make it exceedingly improbable that the carcinogenic activity of N-2-fluorenylacetamide is mediated through N-(1-hydroxy-2-fluorenyl)acetamide or through the o-quinone imine, 2-imino-1,2-fluorenoquinone, resulting from N-(1-hydroxy-2-fluorenyl)acetamide by the sequential reactions of deacetylation and oxidation.

1 This investigation was supported by USPHS Research Grant CA-02571 from the National Cancer Institute.

Received 6/28/67. Accepted 10/ 5/67.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1968 by the American Association for Cancer Research.